PRESS RELEASE published on 12/08/2025 at 07:30, 11 months 13 days ago Eight years of research and development – proprietary algorithms enable the strategic scaling of trading capacities Alphawave GmbH concludes an 8-year R&D phase, introducing scalable trading capacities. Proprietary algorithms drive strategic trading. Impressive internal trading results shared Research And Development Trading Capacities Proprietary Algorithms Alphawave GmbH Internal Trading Results
PRESS RELEASE published on 12/08/2025 at 07:05, 11 months 13 days ago Huawei Celebrates Türkiye's Leading Developers and Designers at Istanbul Awards Event Huawei celebrates Türkiye's leading app developers and watch face designers at Istanbul Awards event, reinforcing commitment to innovation and local talent Innovation Türkiye Designers Developers Huawei
PRESS RELEASE published on 12/08/2025 at 07:00, 11 months 13 days ago Xlife Sciences AG Announces Exit of 12 Project Companies to Grupo Landsteiner and the Creation of a Scalable Transcontinental Life Sciences Platform Xlife Sciences AG announces strategic exit of 12 projects to Grupo Landsteiner, forming a transcontinental life sciences platform with a NASDAQ listing in 2026 Life Sciences Nasdaq Listing Xlife Sciences AG Strategic Exit Grupo Landsteiner
PRESS RELEASE published on 12/08/2025 at 07:00, 11 months 13 days ago Helvetia Baloise publishes Pro Forma Financial Information Helvetia Baloise successfully completes merger with Baloise, forming Helvetia Baloise, Switzerland's largest insurer. Pro Forma Financial Information released showing accounting effects Merger Intangible Assets Helvetia Baloise Pro Forma Financial Information IFRS Accounting Adjustments
PRESS RELEASE published on 12/08/2025 at 07:00, 11 months 13 days ago Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology
PRESS RELEASE published on 12/08/2025 at 07:00, 11 months 13 days ago Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz Evotec closes sale of Just - Evotec Biologics' Toulouse site to Sandoz for over US$650m, including technology license fees. Sale improves revenue mix and profit margins Technology Sale Evotec Sandoz Biologics
PRESS RELEASE published on 12/08/2025 at 07:00, 11 months 13 days ago Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals initiates ENIGMA-TRS 2 Phase III global clinical study in US for treatment-resistant schizophrenia with evenamide as add-on therapy. Expecting results by Q4 2026 Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS 2
PRESS RELEASE published on 12/08/2025 at 04:30, 11 months 13 days ago Family Support Now Make-or-Break for Overseas Postings, New Study Reveals New research from AXA Global Healthcare reveals the importance of family support for international assignees, urging employers to adopt a more holistic approach. The 2025 World of Work Report emphasizes the impact on assignees' wellbeing and success criteria on global placements Employee Wellbeing International Assignments AXA Global Healthcare Family Support Global Mobility
PRESS RELEASE published on 12/07/2025 at 18:00, 11 months 14 days ago IBC Advanced Alloys Reports Results from its 2025 Annual General Meeting IBC Advanced Alloys Corp. announces results of 2025 Annual General Meeting in Centennial, CO. Shareholders re-elected board members and approved key resolutions Board Of Directors Annual General Meeting Shareholders IBC Advanced Alloys Corp. Resolutions
PRESS RELEASE published on 12/07/2025 at 09:00, 11 months 14 days ago Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering Onco-Innovations engages U.S. investment bank for potential Nasdaq cross-listing and equity financing, part of long-term corporate development strategy Equity Financing Nasdaq Investment Bank Onco-Innovations Cross-listing
Published on 11/20/2026 at 15:00, 1 day 7 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 1 day 7 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 8 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 9 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 9 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 22 hours 56 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 21:36, 1 day 1 hour ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 19:26, 1 day 3 hours ago EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Published on 11/20/2026 at 19:03, 1 day 3 hours ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:34, 1 day 4 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 5 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 3 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 2 days 14 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing